Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paula Chiarella

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Medicina|December 15, 2011
On the immunostimulatory hypothesis of cancerJuan Bruzzo, Paula Chiarella, Raúl A Ruggiero
Frontiers in Oncology|March 7, 2022
Editorial: Ageing and CarcinogenesisRaúl A Ruggiero, Paula Chiarella, Carlos María Galmarini
Journal of Cancer Research and Clinical Oncology|August 12, 2010
Biphasic effect of a primary tumor on the growth of secondary tumor implantsJuan Bruzzo, Paula Chiarella, Roberto P Meiss, et al.
Cancer Letters|May 29, 2012
Concomitant tumor resistancePaula Chiarella, Juan Bruzzo, Roberto P Meiss, et al.
Medicina|December 7, 2007
[Systemic inflammation and experimental cancer in a murine model]Juan Bruzzo, Paula Chiarella, Gabriela Fernández, et al.
Clinical Medicine. Oncology|September 6, 2011
Therapeutic anti-tumor vaccines: from tumor inhibition to enhancementPaula Chiarella, Verónica Reffo, Juan Bruzzo, et al.
Medicina|September 13, 2008
[Unveiling antigens in a non-immunogenic spontaneous murine tumor using a dendritic cell based vaccine]Verónica L Reffo, Paula Chiarella, Juan Bruzzo, et al.
Medicina|February 1, 2015
Meta-tyrosine. A powerful anti-metastatic factor with undetectable toxic-side effectsDamián Machuca, Paula Chiarella, Daniela Montagna, et al.
Cancer Research|February 9, 2012
Concomitant tumor resistance: the role of tyrosine isomers in the mechanisms of metastases controlRaúl A Ruggiero, Juan Bruzzo, Paula Chiarella, et al.
BMC Cancer|August 3, 2022
Inhibition of hyperprogressive cancer disease induced by immune-checkpoint blockade upon co-treatment with meta-tyrosine and p38 pathway inhibitorDaniela R Montagna, Alejandra Duarte, Paula Chiarella, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Medicina|December 15, 2011
On the immunostimulatory hypothesis of cancerJuan Bruzzo, Paula Chiarella, Raúl A Ruggiero
Frontiers in Oncology|March 7, 2022
Editorial: Ageing and CarcinogenesisRaúl A Ruggiero, Paula Chiarella, Carlos María Galmarini
Journal of Cancer Research and Clinical Oncology|August 12, 2010
Biphasic effect of a primary tumor on the growth of secondary tumor implantsJuan Bruzzo, Paula Chiarella, Roberto P Meiss, et al.
Cancer Letters|May 29, 2012
Concomitant tumor resistancePaula Chiarella, Juan Bruzzo, Roberto P Meiss, et al.
Medicina|December 7, 2007
[Systemic inflammation and experimental cancer in a murine model]Juan Bruzzo, Paula Chiarella, Gabriela Fernández, et al.
Clinical Medicine. Oncology|September 6, 2011
Therapeutic anti-tumor vaccines: from tumor inhibition to enhancementPaula Chiarella, Verónica Reffo, Juan Bruzzo, et al.
Medicina|September 13, 2008
[Unveiling antigens in a non-immunogenic spontaneous murine tumor using a dendritic cell based vaccine]Verónica L Reffo, Paula Chiarella, Juan Bruzzo, et al.
Medicina|February 1, 2015
Meta-tyrosine. A powerful anti-metastatic factor with undetectable toxic-side effectsDamián Machuca, Paula Chiarella, Daniela Montagna, et al.
Cancer Research|February 9, 2012
Concomitant tumor resistance: the role of tyrosine isomers in the mechanisms of metastases controlRaúl A Ruggiero, Juan Bruzzo, Paula Chiarella, et al.
BMC Cancer|August 3, 2022
Inhibition of hyperprogressive cancer disease induced by immune-checkpoint blockade upon co-treatment with meta-tyrosine and p38 pathway inhibitorDaniela R Montagna, Alejandra Duarte, Paula Chiarella, et al.
Pageof 2